SMTL ID : 8w5c.1

Crystal structure of FGFR4 kinase domain in complex with 8K

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

homo-dimer

Ligands

2 x VZO: N-[5-cyano-4-(2-methoxyethylamino)pyridin-2-yl]-5-methanoyl-6-[(4-methylpiperazin-1-yl)methyl]-1-propan-2-yl-pyrrolo[3,2-b]pyridine-3-carboxamide(Covalent)

VZO.1: 16 residues within 4Å: Chain A: L.21, G.22, V.29, R.31, T.47, V.48, A.49, K.51, I.82, V.98, E.99, C.100, A.101, A.102, G.104, L.167 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:R.31 Hydrogen bonds: A:T.47, A:K.51, A:A.101, A:G.104 VZO.2: 15 residues within 4Å: Chain B: L.21, V.29, V.48, A.49, K.51, I.82, V.98, E.99, C.100, A.101, A.102, G.104, L.167, E.170, D.178 4 PLIP interactions: 4 interactions with chain B Hydrophobic interactions: B:L.167 Hydrogen bonds: B:K.51, B:A.101, B:G.104

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Yang, F. et al., Discovery of 6-Formylpyridyl Urea Derivatives as Potent Reversible-Covalent Fibroblast Growth Factor Receptor 4 Inhibitors with Improved Anti-Hepatocellular Carcinoma Activity. J.Med.Chem. (2024)

Release Date

2024-07-31

Peptides

Fibroblast growth factor receptor 4: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Fibroblast growth factor receptor 4